<DOC>
	<DOCNO>NCT01849484</DOCNO>
	<brief_summary>This randomized trial examines possible enhancement live quality neurocognitive function patient radiotherapy neurocranial area hippocampal spar . Although hippocampus crucial role regard neurocognition memory , hippocampal region relatively disregard radiotherapy neurocranium far . Brain metastases hippocampal region rare infiltration hippocampus meningioma pituitary adenoma occur volume tumor high . This study aim reduce radiation dose hippocampal region improve quality live neurocognitive function patient without degrade prognosis increase probability brain metastasis hippocampal region . Primary endpoint trial quality live neurocognitive function patient radiation neurocranial region hippocampal spar compare conventional radiotherapy neurocranial region without hippocampal sparing . Secondary endpoint cerebral recurrence rate hippocampal region overall survival . It plan include total number 150 patient .</brief_summary>
	<brief_title>Enhancement Neurocognitive Functions Hippocampal Sparing Radiotherapy</brief_title>
	<detailed_description />
	<criteria>minimum age 18 disease indicate radiotherapy neurocranial area ( histologically imageguided confirm ( skull base ) meningioma , pituitary adenoma , brain metastasis , SCLC ) indication local radiotherapy neurocranial area radiation whole neurocranium KarnofskyState â‰¥ 50 % patient understand content study protocol Signed studyspecific consent form prior therapy Exclusion Criteria pregnant nursing woman Fertile patient refuse effective contraception study treatment persistent drug and/or alcohol abuse prior radiotherapy neurocranial region patient able willing behave accord study protocol case malignancy : 3 brain metastasis case malignancy : brain metastasis hippocampal region hippocampus avoidance zone GTV hippocampal region hippocampus avoidance zone patient care patient able speak German condition preclude application MRT ( e.g . magnetic implant , cardiac pacemaker ) ontreatment participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>meningioma</keyword>
	<keyword>skull base meningioma</keyword>
	<keyword>pituitary adenoma</keyword>
	<keyword>brain metastasis</keyword>
	<keyword>small cell lung carcinoma</keyword>
</DOC>